glp-1 anesthesia Are Serious Risks of Semaglutide and Other Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia GLP-1 Medication Disclosure Before Anesthesia:
Description
Norgaard, C
The most common side effect of Toujeo is low blood sugar (hypoglycemia), which may be serious and life-threatening
Successful weight loss involves monitoring how you feel just as much as what the lab says
According to the findings, 36% of current GLP-1 users report currently microdosing, 32% of users say they used to microdose in the past, but have stopped, and 32% say they have never microdosed
Most patients see meaningful results within the first 8 to 12 weeks
Instead, they fall into the titration camp
